Sucratas-O is a prescription medication presented as a 200 ml suspension, combining Sucralfate and Oxetacaine. It is manufactured by Aagya Biotech Pvt. Ltd. and marketed by Intas Pharmaceuticals Ltd. Each 10 ml of this suspension contains 1 g of Sucralfate IP and 10 mg of Oxetacaine IP in a flavoured palatable base, colored with Erythrosine. The medication is typically used to treat stomach and duodenal ulcers by forming a protective layer over the ulcerated tissue. The addition of Oxetacaine, a local anesthetic, helps to provide rapid relief from pain associated with ulcers and inflammation. The dosage should be taken exactly as directed by a physician. It is crucial to shake the bottle well before use to ensure the suspension is properly mixed. Store Sucratas-O in a cool place, protected from direct sunlight, and always keep it out of reach of children. The product is a Schedule H Prescription Drug, requiring a prescription from a registered medical practitioner. The packaging is a cardboard box featuring an illustration of the human stomach, clearly indicating its intended use for gastrointestinal conditions.